Look for:

Our offer for

BAYER AG


ISIN:
DE000BAY0017
WKN:
BAY001

2024/02/21 16:11:49
Price
28.855 EUR
Difference 0.31% (0.09)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)28,259 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)28.855 EUR (1,014)
Ask (Ask size)28.865 EUR (3,464)
Open28.71 EUR
High29.095 EUR
Low28.37 EUR
Close (prev. day)28.765 EUR
VWAP28.82481 EUR
Volume (pcs)2,473,099
Trading volume71,286,612.22
Number of trades8,977
Last size110

Futures and Options

Related Futures54
Related Options-

PDF Downloads

Company report: BAYER AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/02/21 16:11:49
Price
28.855 EUR
Difference 0.31% (0.09)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeXetra
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)28,259 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)28.855 EUR (1,014)
Ask (Ask size)28.865 EUR (3,464)
Open28.71 EUR
High29.095 EUR
Low28.37 EUR
Close (prev. day)28.765 EUR
VWAP28.82481 EUR
Volume (pcs)2,473,099
Trading volume71,286,612.22
Number of trades8,977
Last size110

Performance and Risk

6m1Y3Y
Perf (%)-43.03%-51.22%-46.65%
Perf (abs.)-21.71-30.18-25.13
Beta1.291.000.79
Volatility37.6031.6229.01
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)28.480 EUR (4,825,503)
Ø price 30 days | Ø volume 30 days (pcs.)30.610 EUR (4,504,469)
Ø price 100 days | Ø volume 100 days (pcs.)35.504 EUR (4,178,737)
Ø price 250 days | Ø volume 250 days (pcs.)46.276 EUR (2,952,343)
YTD High | date36.090 EUR (2024/01/08)
YTD Low | date27.400 EUR (2024/02/09)
52 Weeks High | date61.910 EUR (2023/04/18)
52 Weeks Low | date27.400 EUR (2024/02/09)

All listings for BAYER AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
BX Swiss2024/02/2115:5327.619 CHF0.069
Berlin2024/02/2115:3628.92 EUR0.0413
Bucharest Stock Exchange2024/02/2111:09144.00 RON0.016
Budapest Stock Exchange2024/02/2114:1711,226.00 HUF3.944
Duesseldorf2024/02/2115:0028.835 EUR0.026
Euronext Milan MTF Global Equity Market2024/02/2116:0128.895 EUR0.46101
Euronext Milan MTF Trading After Hours2024/02/1920:0528.50 EUR0.026
FINRA other OTC Issues2024/02/2018:3831.043 USD0.0818
Frankfurt2024/02/2115:5628.95 EUR0.3649
Hamburg2024/02/2115:3128.90 EUR0.1111
Hanover2024/02/2115:0528.88 EUR0.013
London Stock Exchange European Trade Reporting2024/02/2109:0028.72 EUR0.005
Munich2024/02/2114:4828.77 EUR0.066
SIX Swiss Exchange2023/02/2117:3560.00 EUR0.001
SIX Swiss Exchange2022/06/0215:20195.7691 CHF0.001
Stuttgart2024/02/2116:1128.86 EUR1.24175
Tradegate2024/02/2116:1128.86 EUR10.701,176
Vienna Stock Exchange2024/02/2109:0528.955 EUR0.001
Xetra2024/02/2116:1228.855 EUR71.298,977

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=958&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAYER AG
- -
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen
Telefon: +49-214-30-1
Fax: +
E-mail: -

PDF Downloads

Company report: BAYER AGPDF Download

Company Profile

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Members of Management Board

Werner BaumannChairman of Managing Board
Heiko SchipperMember of Executive Committee
Rodrigo SantosMember of Executive Committee
Sarena LinMember of Executive Committee
Stefan OelrichMember of Executive Committee
Wolfgang NicklMember of Executive Committee

Board of directors

Norbert WinkeljohannChairman of Supervisory Board
Barbara GansewendtMember of Supervisory Board
Norbert BischofbergerMember of Supervisory Board
Otmar WiestlerMember of Supervisory Board
Paul AchleitnerMember of Supervisory Board
Simone Bagel-TrahMember of Supervisory Board
Alberto WeisserMember of Supervisory Board
Andrea SacherMember of Supervisory Board
André van BroichMember of Supervisory Board
Claudia SchadeMember of Supervisory Board
Colleen GogginsMember of Supervisory Board
Ertharin CousinMember of Supervisory Board
Francesco GrioliMember of Supervisory Board
Frank LöllgenMember of Supervisory Board
Heike HausfeldMember of Supervisory Board
Heinz Georg WebersMember of Supervisory Board
Horst Heinz Paul BaierMember of Supervisory Board
Kimberly MathisenMember of Supervisory Board
Michael WestmeierMember of Supervisory Board
Yasmin FahimiMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer